• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP CANADA INC. MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE, HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP CANADA INC. MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE, HEART VALVE Back to Search Results
Model Number LXA
Device Problems Gradient Increase (1270); Material Integrity Problem (2978)
Patient Problems Death (1802); Failure of Implant (1924)
Event Date 01/14/2014
Event Type  Other  
Event Description
The mfr was notified on (b)(4) 2014 with a email from the hosp that of a mitroflow valve (lxa size 19) that was explanted after 1 year and 7 months due a reported high gradient secondary to an early structural valve deterioration in a young pt.On (b)(6) 2014, on the journal "circulation: the following article was published "accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults".On the list of pts that received a mitroflow valve and experimented the mitroflow explant, the mfr identified that the pt died after the explantation of the mitroflow valve.No details of the cause of death were provided.
 
Manufacturer Narrative
Device eval by mfr: sorin received the explanted valve, the investigation is still ongoing.Eval, method = the results of the device history record review confirmed the device met all material, dimensional, and performance requirements at the time of mfr and release.Results = no definitive results at this time.No conclusion can be drawn at this time as the histological analysis is still ongoing.Corrected date: the following boxes were modified for correction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITROFLOW AORTIC PERICARDIAL HEART VALVE
Type of Device
TISSUE, HEART VALVE
Manufacturer (Section D)
SORIN GROUP CANADA INC.
burnaby, bc
CA 
Manufacturer (Section G)
SORIN GROUP CANADA INC.
5005 north fraser way
burnaby, bc V5J 5M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
4125696
MDR Report Key4575501
MDR Text Key5560547
Report Number3004478276-2014-00006
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 02/14/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date02/28/2017
Device Model NumberLXA
Device Catalogue NumberLXA19
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer02/05/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/19/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age22 YR
Patient Weight35
-
-